American Bio Medica Corp ABMC:OTCQB

RT Quote | Exchange | USD
Last | 03/02/21 EST
0.1629UNCH (UNCH)
52 week range
0.06 - 1.26


Loading . . .


  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1629
  • 52 Week High1.26
  • 52 Week High Date06/25/20
  • 52 Week Low0.06
  • 52 Week Low Date03/18/20
  • Market Cap6.14M
  • Shares Out37.70M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-1.92
  • 1 Year % Change141.33


  • EPS (TTM)-0.02
  • P/E (TTM)-6.92
  • Fwd P/E (NTM)5.43
  • EBITDA (MRQ)-530,000.00
  • ROE (MRQ)-18,218.18%
  • Revenue (MRQ)4.25M
  • Gross Margin (MRQ)28.73%
  • Net Margin (MRQ)-18.89%
  • Debt To Equity (MRQ)-150.91%


  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest American Bio Medica Corp News

There is no recent news for this security.

Latest ABMC News From Our Partners

There is no recent news for this security.



American Bio Medica Corporation develops, manufactures and sells immunoassay tests, primarily for the immediate, point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The Company's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. In addition to the manufacture and sale of DOA POCT products, the Company provides bulk test strip manufacturing services to...
Melissa Waterhouse
Chief Executive Officer
Lawrence Ferringo
Vice President
122 Smith Rd
Kinderhook, NY
United States